Find out how two key acquisitions and one of our largest product launches in history helped us enter the neuromodulation field and establish ourselves as a global leader in cardiovascular medicine. Find out how two key acquisitions and one of our largest product launches in history helped us enter the neuromodulation field and establish ourselves as a global leader in cardiovascular medicine.

  


Meaningful Innovation

  

The 2004 launch of this paclitaxel-eluting coronary stent system in the U.S. was one of the largest and most successful product launches in industry history. The 2004 launch of this paclitaxel-eluting coronary stent system in the U.S. was one of the largest and most successful product launches in industry history.

  


Growth and Acquisitions

  

The 2006 acquisition of Guidant was the largest in company history, solidifying Boston Scientific as a global leader in cardiovascular medicine. | The 2004 acquisition of Advanced Bionics gave the company entry into the field of neuromodulation. The 2006 acquisition of Guidant was the largest in company history, solidifying Boston Scientific as a global leader in cardiovascular medicine. | The 2004 acquisition of Advanced Bionics gave the company entry into the field of neuromodulation. Top